SEC Form 4 · accession 0001179110-15-014423
IMMUNOGEN INC · IMGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel M Junius
Officer — Chief Executive Officer · Director
Period of report
Nov 3, 2015
Accepted (ET)
Nov 4, 2015 · 10:42 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000855654
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 3, 2015 | M | 5,907 | $4.29 | A | 170,618 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.29 | Nov 3, 2015 | M | 5,907 | D | Jan 1, 2010 | Jan 1, 2019 | Common Stock | 5,907 | 188,518 | D |
Explanation of responses
- F1Exercisable as to 50,000 shares commencing on January 1, 2010, 50,000 shares commencing on January 1, 2011, 50,000 shares commencing on January 1, 2012 and 50,000 shares commencing on January 1, 2013.